---
title: "Dynamic SV2A PET reveals perfusion and synaptic alterations in Parkinson’s disease"
id: "medrxiv-20-alterations-in-relative-perfusion-and-synaptic-patterns-in-parkinson-s-disease"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-20-alterations-in-relative-perfusion-and-synaptic-patterns-in-parkinson-s-disease"
content_type: "clinical_feed_article"
specialty: "Neurology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.28.26364237v1?rss=1"
published_at: "2026-09-29T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Dynamic SV2A PET reveals perfusion and synaptic alterations in Parkinson’s disease
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-20-alterations-in-relative-perfusion-and-synaptic-patterns-in-parkinson-s-disease
- **Specialty:** [Neurology](https://medichelpline.com/clinical-feed/neurology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.28.26364237v1?rss=1)
- **Published At:** 2026-09-29T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Study used dynamic **[11C]UCB-J PET** to measure both **synaptic density** (BPND) and **relative perfusion** (R1) in 30 Parkinson’s disease (PD) patients and 30 controls. - A spatial covariance analysis on R1 identified a Parkinson’s disease–related perfusion network (**PDRP**) with significantly higher expression in PD (p=1.7×10−5, Cohen’s d=1.2). - **PDRP expression** correlated with motor severity measured by **MDS‑UPDRS III** (r=0.57, p=0.0009). - Combining PDRP expression with synaptic density in the **substantia nigra** explained 48% of variance in MDS‑UPDRS Part III—about double the variance explained by nigral synaptic density alone as previously reported. - Whole‑brain cluster analysis revealed two large occipital‑parietal clusters where R1 correlated negatively with **tremor severity** (r ≈ −0.65, p<0.001), suggesting regional perfusion relates to tremor independent of dopaminergic losses. - Inter‑individual regional correlation patterns were altered in PD for both BPND and R1; synaptic density changes prominently involved the pallidum, while perfusion alterations prominently involved the thalamus. - Authors conclude that integrating synaptic and perfusion measures from dynamic **[11C]UCB-J PET** captures complementary physiological alterations in PD and explains more motor symptom variation than synaptic measures alone. - Ethical approvals were obtained from Yale University committees and participants provided informed consent; raw data are available from the principal investigator upon request. - Funding sources included NINDS (R01NS124819) and AbbVie; two authors are AbbVie employees and declared that employment does not constitute a conflict for this work.
## Clinical Analysis & Structured Key Points
Alterations in relative perfusion and synaptic patterns in Parkinson′s disease using dynamic SV2A PET | medRxiv Skip to main content Alterations in relative perfusion and synaptic patterns in Parkinson′s disease using dynamic SV2A PET View ORCID Profile Praveen Honhar , View ORCID Profile Sule Tinaz , Faranak Ebrahimian Sadabad , Jean-Dominique Gallezot , Mika Naganawa , Mark Dias , Yunpeng Ye , Hong Gao , Nabeel Nabulsi , Yiyun Huang , Sophie E Holmes , Robert A Comley , Ansel T Hillmer , Sjoerd J Finnema , David Matuskey , Richard E Carson doi: https://doi.org/10.64898/2026.09.28.26364237 Praveen Honhar 1 Yale University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Praveen Honhar For correspondence: phonhar{at}mgh.harvard.edu Sule Tinaz 2 Yale School of Medicine; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Sule Tinaz Faranak Ebrahimian Sadabad 1 Yale University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Jean-Dominique Gallezot 1 Yale University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Mika Naganawa 1 Yale University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Mark Dias 1 Yale University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Yunpeng Ye 1 Yale University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Hong Gao 1 Yale University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Nabeel Nabulsi 1 Yale University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Yiyun Huang 1 Yale University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Sophie E Holmes 1 Yale University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Robert A Comley 3 Abbvie Inc.; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Ansel T Hillmer 1 Yale University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Sjoerd J Finnema 4 Abbvie Inc Find this author on Google Scholar Find this author on PubMed Search for this author on this site David Matuskey 1 Yale University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Richard E Carson 1 Yale University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Abstract Info/History Metrics Supplementary material Data/Code Preview PDF Abstract Purpose Dynamic [11C]UCB-J PET can simultaneously provide information about synaptic density and relative perfusion in Parkinson′s disease (PD). We investigated whether these complementary biomarkers could explain a higher percentage of motor symptom severity variation in PD and inform other PD-specific physiological alterations and symptomatology. Methods Binding potential (BP ND ) and relative perfusion (R 1 ) images were derived 30 PD and 30 controls imaged with [11C]UCB-J PET. A spatial covariance analysis was used on R 1 to derive PDRP-a known metabolic network alteration in PD. Linear models related PD-motor symptom severity to PDRP expression and nigral synaptic losses. Next, whole-brain cluster analyses identified physiological correlates for PD-tremor severity, a prominent motor symptom that does not correlate with dopaminergic losses. Lastly, inter-individual regional correlation alterations in PD were examined for both BP ND and R 1 . Results PDRP was identified from R 1 , with higher expression in PD (p=1.7x10-5, Cohen′s d =1.2), and its expression correlated with MDS-UPDRS III (r=0.57, p=0.0009). Combining PDRP expression scores with synaptic density in the substantia nigra explained 48% of the total variation in MDS-UPDRS Part III, twice as much as previously reported using nigral synaptic density alone. Two significant large clusters (p k <1x10-6) were identified in the occipital-parietal areas where R 1 was negatively correlated with tremor severity (r ~ -0.65, p<0.001). Extensive correlation alterations were observed in synaptic density (prominently involving pallidum) and perfusion (prominently involving thalamus). Conclusions Combining synaptic and perfusion outcomes for [11C]UCB-J PET explains more physiological alterations associated with PD. Competing Interest Statement Robert Comley and Sjoerd J Finnema are full time employees of Abbvie, but their employment does not constitute a conflict of interest for the research reported in this work. All other authors declare no conflict of interest. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Yale University Human Investigation Committee/Institutional Review Board and Radiation Safety Committee at Yale University gave ethical approval for this study and all participants signed informed consent forms. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability Raw data on which this work is based is available from the principal investigator (Dr. David Matuskey, david.matuskey{at}yale.edu) upon request. Funder Information Declared National Institute of Neurological Disorders and Stroke, https://ror.org/01s5ya894 , 1R01NS124819 AbbVie (United States), https://ror.org/02g5p4n58 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . Back to top Previous Next Posted September 29, 2026. Download PDF Supplementary Material Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Alterations in relative perfusion and synaptic patterns in Parkinson′s disease using dynamic SV2A PET Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Alterations in relative perfusion and synaptic patterns in Parkinson′s disease using dynamic SV2A PET Praveen Honhar , Sule Tinaz , Faranak Ebrahimian Sadabad , Jean-Dominique Gallezot , Mika Naganawa , Mark Dias , Yunpeng Ye , Hong Gao , Nabeel Nabulsi , Yiyun Huang , Sophie E Holmes , Robert A Comley , Ansel T Hillmer , Sjoerd J Finnema , David Matuskey , Richard E Carson medRxiv 2026.09.28.26364237; doi: https://doi.org/10.64898/2026.09.28.26364237 Share This Article: Copy Citation Tools Alterations in relative perfusion and synaptic patterns in Parkinson′s disease using dynamic SV2A PET Praveen Honhar , Sule Tinaz , Faranak Ebrahimian Sadabad , Jean-Dominique Gallezot , Mika Naganawa , Mark Dias , Yunpeng Ye , Hong Gao , Nabeel Nabulsi , Yiyun Huang , Sophie E Holmes , Robert A Comley , Ansel T Hillmer , Sjoerd J Finnema , David Matuskey , Richard E Carson medRxiv 2026.09.28.26364237; doi: https://doi.org/10.64898/2026.09.28.26364237 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Area Neurology Subject Areas All Articles Addiction Medicine (622) Allergy and Immunology (909) Anesthesia (339) Cardiovascular Medicine (4862) Dentistry and Oral Medicine (482) Dermatology (420) Emergency Medicine (656) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1639) Epidemiology (16029) Forensic Medicine (34) Gastroenterology (1214) Genetic and Genomic Medicine (7107) Geriatric Medicine (735) Health Economics (1071) Health Informatics (5099) Health Policy (1441) Health Systems and Quality Improvement (1786) Hematology (588) HIV/AIDS (1351) Infectious Diseases (except HIV/AIDS) (16342) Intensive Care and Critical Care Medicine (1181) Medical Education (675) Medical Ethics (156) Nephrology (728) Neurology (7354) Nursing (370) Nutrition (1096) Obstetrics and Gynecology (1253) Occupational and Environmental Health (1008) Oncology (3645) Ophthalmology (1063) Orthopedics (399) Otolaryngology (459) Pain Medicine (480) Palliative Medicine (140) Pathology (710) Pediatrics (1816) Pharmacology and Therapeutics (740) Primary Care Research (772) Psychiatry and Clinical Psychology (5956) Public and Global Health (9810) Radiology and Imaging (2453) Rehabilitation Medicine and Physical Therapy (1468) Respiratory Medicine (1255) Rheumatology (646) Sexual and Reproductive Health (780) Sports Medicine (586) Surgery (785) Toxicology (107) Transplantation (309) Urology (296)
## Related Clinical Research

- [Ultra-processed foods linked to MRI signs of vascular brain injury in middle-aged adults](https://medichelpline.com/clinical-feed/medical-news-today-0-ultra-processed-foods-may-be-harming-brain-health-in-otherwise-healthy-adults.md)
- [Global dementia incidence projected to reach 24.7 million new cases annually by 2050](https://medichelpline.com/clinical-feed/medical-news-today-0-dementia-cases-to-double-by-2050-why-women-some-countries-may-be-at-higher-risk.md)
- [Pre-diagnostic 1-year prevalence of polypharmacy and PIMcog in Norwegian outpatients with MCI or d](https://medichelpline.com/clinical-feed/plos-one-14-one-year-pre-diagnostic-prevalence-and-associated-factors-of-polypharmacy-and.md)
- [SniffCell: Cell-type-resolved somatic variant discovery from bulk long-read sequencing](https://medichelpline.com/clinical-feed/medrxiv-11-cell-type-resolved-somatic-variant-discovery-from-bulk-long-read-sequencing.md)
- [Spatiotemporal Immunometabolic Remodeling After Acute Traumatic Brain Injury Revealed by Labeled P](https://medichelpline.com/clinical-feed/biorxiv-4-distinct-spatiotemporal-immunometabolic-remodeling-following-acute-traumatic.md)

## Navigation
- [← Back to Neurology Feed](https://medichelpline.com/clinical-feed/neurology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.